Suppr超能文献

PepTherDia:已批准的肽治疗药物和诊断试剂的数据库和结构组成分析。

PepTherDia: database and structural composition analysis of approved peptide therapeutics and diagnostics.

机构信息

School of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, Liverpool L3 3AF, UK.

Institute of Chemical Sciences, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK.

出版信息

Drug Discov Today. 2021 Jun;26(6):1409-1419. doi: 10.1016/j.drudis.2021.02.019. Epub 2021 Feb 26.

Abstract

As of 2020, there were >100 approved peptides with therapeutic or diagnostic applications. However, a complete database providing information on marketed peptides is not freely available, making the peptide chemists' job of designing future peptide drug candidates challenging. Unlike the rules for small-molecule drugs, there is no general set of guidelines for designing a successful peptide-based drug. In this review, together with our freely available database (PepTherDia, http://peptherdia.herokuapp.com), we provide insights into what a successful peptide therapeutic or diagnostic agent looks like and lay the foundation for establishing a set of rules to help future medicinal chemists to design peptide candidates with increased approval rates.

摘要

截至 2020 年,已有超过 100 种经过批准的具有治疗或诊断应用的肽。然而,一个提供有关市售肽信息的完整数据库并不免费提供,这使得设计未来肽类药物候选物的肽化学家的工作具有挑战性。与小分子药物的规则不同,设计成功的基于肽的药物没有一套通用的指导方针。在这篇综述中,我们结合我们免费提供的数据库(PepTherDia,http://peptherdia.herokuapp.com),深入了解成功的肽治疗或诊断剂的外观,并为建立一套规则奠定基础,以帮助未来的药物化学家设计批准率更高的肽候选物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验